{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T07:52:09Z","timestamp":1773906729118,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Drug Innovation Major Project","award":["2018ZX09721002-001-004"],"award-info":[{"award-number":["2018ZX09721002-001-004"]}]},{"name":"National Natural Science","award":["81874297"],"award-info":[{"award-number":["81874297"]}]},{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","award":["ZY2017202"],"award-info":[{"award-number":["ZY2017202"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.ejmech.2020.112259","type":"journal-article","created":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T11:10:26Z","timestamp":1586171426000},"page":"112259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Design, synthesis and discovery of 2(1H)-quinolone derivatives for the treatment of pulmonary fibrosis through inhibition of TGF-\u03b2\/smad dependent and independent pathway"],"prefix":"10.1016","volume":"197","author":[{"given":"Linlin","family":"Xue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dexin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoujun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minghai","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heying","family":"Pei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kongjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoyu","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2020.112259_bib1","first-page":"797","article-title":"Idiopathic pulmonary fibrosis","volume":"379","author":"David","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2020.112259_bib2","first-page":"F1000Res","volume":"vol. 5","author":"C\u00e9cile","year":"2016"},{"key":"10.1016\/j.ejmech.2020.112259_bib3","first-page":"844","article-title":"Advances in understanding of idiopathic pulmonary fibrosis","volume":"122","author":"Wang","year":"2009","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.ejmech.2020.112259_bib4","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/S0140-6736(17)30866-8","article-title":"Idiopathic pulmonary fibrosis","volume":"389","author":"Luca","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2020.112259_bib5","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1401739","article-title":"Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis","volume":"370","author":"Martinez","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2020.112259_bib6","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1056\/NEJMoa1113354","article-title":"Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis","volume":"366","author":"Raghu","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2020.112259_bib7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa030511","article-title":"A\u00a0placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis","volume":"350","author":"Raghu","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2020.112259_bib8","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1164\/rccm.201202-0314OC","article-title":"A\u00a0placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis","volume":"186","author":"Noth","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejmech.2020.112259_bib9","first-page":"309","article-title":"Managing comorbidities in idiopathic pulmonary fibrosis","volume":"8","author":"Fulton","year":"2015","journal-title":"Int. J. Gen. Med."},{"key":"10.1016\/j.ejmech.2020.112259_bib10","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1056\/NEJMoa1002110","article-title":"A\u00a0controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis","volume":"363","author":"Zisman","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2020.112259_bib11","doi-asserted-by":"crossref","first-page":"4466","DOI":"10.1021\/jm900431g","article-title":"Design, synthesis, and evaluation of indolinones as triple angiokinase inhibitors and the discovery of a highly specific 6-methoxycarbonyl-substituted indolinone (BIBF 1120)","volume":"52","author":"Roth","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112259_bib12","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.4187\/respcare.03023","article-title":"A\u00a0novel therapeutic approach for idiopathic pulmonary fibrosis","volume":"59","author":"Nintedanib","year":"2014","journal-title":"Respir. Care"},{"key":"10.1016\/j.ejmech.2020.112259_bib13","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2020.112259_bib14","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1021\/jm501562a","article-title":"Nintedanib: from discovery to the clinic","volume":"58","author":"Roth","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112259_bib15","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.resinv.2015.06.001","article-title":"All-case post-marketing surveillance of 1371 patients treated with pirfenidone for idiopathic pulmonary fibrosis","volume":"53","author":"Ogura","year":"2015","journal-title":"Respir. Investig."},{"key":"10.1016\/j.ejmech.2020.112259_bib16","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(11)60052-4","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"Talmadge","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2020.112259_bib17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ejmech.2018.07.074","article-title":"Synthesis and discovery of a drug candidate for treatment of idiopathic pulmonary fibrosis through inhibition of TGF-\u03b21 pathway","volume":"157","author":"Li","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112259_bib18","doi-asserted-by":"crossref","unstructured":"R.E. Gilbert, Y. Zhang, S.J. Williams, et\u00a0al. A purpose-synthesised anti-fibrotic agent attenuates experimental kidney diseases in the rat. PLOS ONE. 7, e47160.","DOI":"10.1371\/journal.pone.0047160"},{"key":"10.1016\/j.ejmech.2020.112259_bib19","article-title":"Synthesis and discovery of new compounds bearing coumarin scaffold for the treatment of pulmonary fibrosis","author":"Deng","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112259_bib20","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1164\/rccm.201202-0314OC","article-title":"Idiopathic pulmonary fibrosis clinical network (IPFnet). A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis","volume":"186","author":"Noth","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejmech.2020.112259_bib21","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1021\/jm9904295","article-title":"Design, synthesis, and evaluations of substituted 3-[(3- or 4-Carboxyethylpyrrol-2-yl)methylidenyl]indolin-2-ones as Inhibitors of VEGF, FGF, and PDGF receptor tyrosine kinases","volume":"42","author":"Sun","year":"1999","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112259_bib22","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1021\/jm040072r","article-title":"Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties","volume":"47","author":"Freeman","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112259_bib23","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/minf.201400037","article-title":"Bioisosteres and scaffold hopping in medicinal chemistry","volume":"33","author":"Brown","year":"2014","journal-title":"Mol. Inform."},{"key":"10.1016\/j.ejmech.2020.112259_bib24","first-page":"F631","article-title":"In\u00a0vitro models of TGF-beta-induced fibrosis suitable for high-throughput screening of antifibrotic agents","volume":"293","author":"Xu","year":"2007","journal-title":"Aust. J. Pharm.: Ren. Physiol."},{"key":"10.1016\/j.ejmech.2020.112259_bib25","doi-asserted-by":"crossref","first-page":"F757","DOI":"10.1152\/ajprenal.00470.2011","article-title":"HSP47 regulates ECM accumulation in renal proximal tubular cells induced by TGF-beta1 through ERK1\/2 and JNK MAPK pathways","volume":"303","author":"Xiao","year":"2012","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.ejmech.2020.112259_bib26","doi-asserted-by":"crossref","first-page":"S258","DOI":"10.1097\/01.CCM.0000057901.92381.75","article-title":"Transforming growth factor-beta: a mediator of cell regulation in acute respiratory distress syndrome","volume":"31","author":"Dhainaut","year":"2003","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ejmech.2020.112259_bib27","first-page":"21","article-title":"Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing","volume":"63","author":"Darby","year":"1990","journal-title":"Lab. Invest."},{"key":"10.1016\/j.ejmech.2020.112259_bib28","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/path.1427","article-title":"The myofibroblast in wound healing and fibro contractive diseases","volume":"200","author":"Gabbiani","year":"2003","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.ejmech.2020.112259_bib29","doi-asserted-by":"crossref","first-page":"L1342","DOI":"10.1152\/ajplung.00035.2004","article-title":"Changes in Smad expression and subcellular localization in bleomycin-induced pulmonary fibrosis","volume":"287","author":"Venkatesan","year":"2004","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.ejmech.2020.112259_bib30","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1096\/fj.03-0037fje","article-title":"Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells","volume":"17","author":"Hayashida","year":"2003","journal-title":"Faseb. J."},{"key":"10.1016\/j.ejmech.2020.112259_bib31","doi-asserted-by":"crossref","first-page":"46707","DOI":"10.1074\/jbc.M106176200","article-title":"Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38 MAPK and epithelial plasticity","volume":"276","author":"Bhowmick","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2020.112259_bib32","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.1242\/jcs.03492","article-title":"MAP-kinase activity necessary for TGF-beta1-stimulated mesangial cell type I collagen expression requires adhesion-dependent phosphorylation of FAK tyrosine 397","volume":"120","author":"Hayashida","year":"2007","journal-title":"J.\u00a0Cell Sci."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420302269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420302269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:08:51Z","timestamp":1759327731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523420302269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":32,"alternative-id":["S0223523420302269"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112259","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and discovery of 2(1H)-quinolone derivatives for the treatment of pulmonary fibrosis through inhibition of TGF-\u03b2\/smad dependent and independent pathway","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112259","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112259"}}